Pura Vida Investments, LLC Concert Pharmaceuticals, Inc. Transaction History

Pura Vida Investments, LLC

  • $140 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$4.34 - $5.84 $896,318 - $1.21 Million
206,525 New
206,525 $1.21 Million
Q2 2022

Aug 15, 2022
BUY
$2.8 - $6.36 $124,199 - $282,110
44,357 New
44,357 $187,000
Q1 2021

May 12, 2021
SELL
$4.86 - $13.07 $1.43 Million - $3.84 Million
-293,443 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$9.48 - $12.84 $2.78 Million - $3.77 Million
293,443 New
293,443 $3.71 Million

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email